Search Results - "chemoembolization"

Quantitative literature analysis on efficacy and safety of balloon-occluded transarterial chemoembolization for hepatocellular carcinoma.

Sui WF; Department of Interventional Radiology, Zhenjiang First People's Hospital, No.8 of Dianli Road, Zhenjiang, Jiangsu Province, China., Duan YX; Department of Interventional Radiology, Zhenjiang First People's Hospital, No.8 of Dianli Road, Zhenjiang, Jiangsu Province, China., Cai ZF; Department of Interventional Radiology, Zhenjiang First People's Hospital, No.8 of Dianli Road, Zhenjiang, Jiangsu Province, China., Li JY; Department of Interventional Radiology, Zhenjiang First People's Hospital, No.8 of Dianli Road, Zhenjiang, Jiangsu Province, China., Fu JH; Department of Interventional Radiology, Zhenjiang First People's Hospital, No.8 of Dianli Road, Zhenjiang, Jiangsu Province, China. suiweifan@126.com.

Journal Article; Meta-Analysis , 2025

Simultaneous versus sequential transcatheter arterial chemoembolization combined with microwave ablation for hepatocellular carcinoma: A retrospective propensity score-matched analysis.

Wang HY; Department of Interventional Therapy, the Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510120, China; Guangdong Provincial Key Laboratory of Chinese Medicine for Prevention and Treatment of Refractory Chronic Diseases, the Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510120, China; Department of Interventional Oncology, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China., Zhang GX; Department of Interventional Oncology, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China., Fan WZ; Department of Interventional Oncology, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China., Li JW; Department of Interventional Therapy, the Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510120, China., Hao SF; Department of Interventional Therapy, the Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510120, China., Ouyang YS; Department of Interventional Therapy, the Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510120, China., Li JP; Department of Interventional Oncology, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China., Liu WD; Department of Interventional Therapy, the Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510120, China. Electronic address: Liu_wendao_2023@163.com.

Journal Article; Comparative Study , 2025

Adjuvant lenvatinib in combination with transarterial chemoembolization for hepatocellular carcinoma patients with high risk of postoperative recurrence: A multicenter prospective cohort study.

Chen JH; Hepatobiliary Surgery Center, Department of General Surgery, Huashan Hospital & Cancer Metastasis Institute, Fudan University, Shanghai 200040, China., Lu L; Hepatobiliary Surgery Center, Department of General Surgery, Huashan Hospital & Cancer Metastasis Institute, Fudan University, Shanghai 200040, China., Zhang XY; Department of Liver Surgery, West China Hospital of Sichuan University, Chengdu 610041, China., Xiang BD; Hepatobiliary Surgery Department, Guangxi Medical University Cancer Hospital, Nanning 537406, China., Xu X; Institute of Translational Medicine, Zhejiang University School of Medicine, Hangzhou 310000, China; Key Laboratory of Integrated Oncology and Intelligent Medicine of Zhejiang Province, Hangzhou 310006, China., Li XC; Hepatobiliary Center, the First Affiliated Hospital, Nanjing Medical University, Key Laboratory of Liver Transplantation, Chinese Academy of Medical Sciences, Nanjing 210029, China., Huang ZY; Hepatic Surgery Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China., Wen TF; Department of Liver Surgery, West China Hospital of Sichuan University, Chengdu 610041, China., Luo LP; Department of Hepatobiliary Surgery, Mengchao Hepatobiliary Hospital, Fujian Medical University, Fuzhou 350025, China., Huang J; Department of Hepato-Pancreato-Biliary Surgery, Ningbo Medical Center Lihuili Hospital, Ningbo University, Ningbo 315048, China., Zhong JH; Hepatobiliary Surgery Department, Guangxi Medical University Cancer Hospital, Nanning 537406, China., Liu ZK; Key Laboratory of Integrated Oncology and Intelligent Medicine of Zhejiang Province, Hangzhou 310006, China; Department of Hepatobiliary and Pancreatic Surgery, Hangzhou First People's Hospital, Hangzhou 310006, China., Li CX; Hepatobiliary Center, the First Affiliated Hospital, Nanjing Medical University, Key Laboratory of Liver Transplantation, Chinese Academy of Medical Sciences, Nanjing 210029, China., Long X; Hepatic Surgery Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China., Zhu WW; Hepatobiliary Surgery Center, Department of General Surgery, Huashan Hospital & Cancer Metastasis Institute, Fudan University, Shanghai 200040, China., Yang X; Hepatobiliary Surgery Center, Department of General Surgery, Huashan Hospital & Cancer Metastasis Institute, Fudan University, Shanghai 200040, China., Wang CQ; Hepatobiliary Surgery Center, Department of General Surgery, Huashan Hospital & Cancer Metastasis Institute, Fudan University, Shanghai 200040, China., Jia HL; Hepatobiliary Surgery Center, Department of General Surgery, Huashan Hospital & Cancer Metastasis Institute, Fudan University, Shanghai 200040, China., Zhang JB; Department of Infectious Diseases, Huashan Hospital, Fudan University, Shanghai 200040, China., Zeng YY; Department of Hepatobiliary Surgery, Mengchao Hepatobiliary Hospital, Fujian Medical University, Fuzhou 350025, China. Electronic address: lamp197311@126.com., Lu CD; Department of Hepato-Pancreato-Biliary Surgery, Ningbo Medical Center Lihuili Hospital, Ningbo University, Ningbo 315048, China. Electronic address: lucaide@nbu.edu.cn., Qin LX; Hepatobiliary Surgery Center, Department of General Surgery, Huashan Hospital & Cancer Metastasis Institute, Fudan University, Shanghai 200040, China. Electronic address: qinlx@fudan.edu.cn.

Clinical Trial; Journal Article; Multicenter Study , 2025

Transarterial chemoembolization plus apatinib for unresectable hepatocellular carcinoma: a multicenter, randomized, open-label, phase III trial.

Kan XF; Department of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China., Liang B; Department of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China., Zhang XL; Department of Interventional Radiology, The First College of Clinical Medical Science, Yichang Central People's Hospital, China Three Gorges University, Yichang, Hubei, China., Yu L; Department of Interventional Radiology, Guangxi Zhuang Autonomous Region People's Hospital, Nanning, China., Luo YC; Department of Catheter Intervention, First Affiliated Hospital of Guangxi, University of Traditional Chinese Medicine, Nanning, China., Zhou S; Department of Interventional Radiology, The Affiliated Cancer Hospital of Guizhou Medical University, Guiyang, China.; Department of Interventional Radiology, The Affiliated Hospital of Guizhou Medical University, Guiyang, China., Liu RB; Department of Interventional Radiology, Harbin Medical University Cancer Hospital, Harbin, China., Xu GH; Department of Interventional Radiology, School of Medicine, Sichuan Cancer Hospital and Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, Chengdu, China., Li HL; Department of Radiology and Intervention, The Affiliated Tumor Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, China., Liao ZY; Department of Abdominal Oncology, West China Medical School, West China Hospital, Sichuan University, Chengdu, China., Xiang H; Department of Interventional Radiology and Vascular Surgery, Hunan Provincial People's Hospital, Changsha, China., Lu W; Department of Interventional Medicine, The Sixth Medical Center of Chinese PLA General Hospital, Beijing, China., Xu LF; Department of Interventional Radiology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China., Ma YL; Department of Interventional Radiology, Guangxi Medical University Cancer Hospital, Guangxi Medical University, Nanning, China., Xia XW; Department of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China., Qian K; Department of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China., Dong XJ; Department of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China., Xiong F; Department of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China., Song SL; Department of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China., Zhao C; Department of Interventional Radiology, Guangxi Medical University Cancer Hospital, Guangxi Medical University, Nanning, China. 710519137@qq.com., Huang M; Department of Minimally Invasive International Therapy, The Third Affiliated Hospital of Kunming University, Tumor Hospital of Yunnan Province, Kunming, Yunnan Province, 650000, China. huangming4328@sina.com., Zheng CS; Department of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China. hqzcsxh@sina.com.

Journal Article; Clinical Trial, Phase III; Randomized Controlled Trial; Multicenter Study , 2025

Efficacy of olanzapine as an antiemetic drug for transcatheter arterial chemoembolization for hepatocellular carcinoma.

Oura K; Department of Gastroenterology and Neurology, Faculty of Medicine, Kagawa University, 1750-1 Ikenobe, Miki, Kita, Kagawa, 761-0793, Japan., Morishita A; Department of Gastroenterology and Neurology, Faculty of Medicine, Kagawa University, 1750-1 Ikenobe, Miki, Kita, Kagawa, 761-0793, Japan. morishita.asahiro@kagawa-u.ac.jp., Manabe T; Department of Gastroenterology and Neurology, Faculty of Medicine, Kagawa University, 1750-1 Ikenobe, Miki, Kita, Kagawa, 761-0793, Japan.; Department of Gastroenterology and Hepatology, Takamatsu Red Cross Hospital, Takamatsu, Kagawa, Japan., Takuma K; Department of Gastroenterology and Neurology, Faculty of Medicine, Kagawa University, 1750-1 Ikenobe, Miki, Kita, Kagawa, 761-0793, Japan., Nakahara M; Department of Gastroenterology and Neurology, Faculty of Medicine, Kagawa University, 1750-1 Ikenobe, Miki, Kita, Kagawa, 761-0793, Japan., Tadokoro T; Department of Gastroenterology and Neurology, Faculty of Medicine, Kagawa University, 1750-1 Ikenobe, Miki, Kita, Kagawa, 761-0793, Japan., Fujita K; Department of Gastroenterology and Neurology, Faculty of Medicine, Kagawa University, 1750-1 Ikenobe, Miki, Kita, Kagawa, 761-0793, Japan., Mimura S; Department of Gastroenterology and Neurology, Faculty of Medicine, Kagawa University, 1750-1 Ikenobe, Miki, Kita, Kagawa, 761-0793, Japan., Tani J; Department of Gastroenterology and Neurology, Faculty of Medicine, Kagawa University, 1750-1 Ikenobe, Miki, Kita, Kagawa, 761-0793, Japan., Ono M; Department of Gastroenterology and Neurology, Faculty of Medicine, Kagawa University, 1750-1 Ikenobe, Miki, Kita, Kagawa, 761-0793, Japan., Sanomura T; Department of Radiology, Faculty of Medicine, Kagawa University, Kita, Kagawa, Japan., Nishiyama Y; Department of Radiology, Faculty of Medicine, Kagawa University, Kita, Kagawa, Japan., Himoto T; Department of Medical Technology, Kagawa Prefectural University of Health Sciences, Takamatsu, Japan., Kobara H; Department of Gastroenterology and Neurology, Faculty of Medicine, Kagawa University, 1750-1 Ikenobe, Miki, Kita, Kagawa, 761-0793, Japan.

Journal Article , 2025

Transarterial chemoembolization combined with tyrosine kinase inhibitors and/or immune checkpoint inhibitors induced hypothyroidism is associated with improved overall survival in hepatocellular carcinoma.

Xu S; Department of Interventional Therapy, The First Hospital of Jilin University, 1# Xinmin St, Changchun, 130021, China., Zheng R; Department of Interventional Therapy, The First Hospital of Jilin University, 1# Xinmin St, Changchun, 130021, China., Sun C; Clinical Collage, The First Hospital of Jilin University, 1# Xinmin St, Changchun, 130021, China., Sa R; Department of Nuclear Medicine, The First Hospital of Jilin University, 1# Xinmin St, Changchun, 130021, China. sari@jlu.edu.cn.

Journal Article , 2025

The impact of immune checkpoint inhibitors on prognosis in unresectable hepatocellular carcinoma treated with TACE and lenvatinib: a meta-analysis.

Zhang W; Department of Hepatobiliary and Pancreatic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, Guangdong, China., Liu Z; Department of Hepatobiliary and Pancreatic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, Guangdong, China., Liu H; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, Guangdong, China., Huang Z; Department of Hepatobiliary and Pancreatic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, Guangdong, China., Huang X; Department of Hepatobiliary and Pancreatic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, Guangdong, China., Xu L; Department of Hepatobiliary and Pancreatic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, Guangdong, China., Che X; Department of Hepatobiliary and Pancreatic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, Guangdong, China., Zhan Z; Department of Hepatobiliary and Pancreatic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, Guangdong, China.

Journal Article; Meta-Analysis; Systematic Review , 2025

Clinical efficacy of TACE using coil or gelatin sponge combined with targeted therapy in the treatment of giant hepatocellular carcinoma with arterioportal fistulas.

Wu Z; Department of Gerontology, Central Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China., Zhang M; Department of Breast and Thyroid Surgery, Affiliated Zhongshan Hospital of Dalian University, Dalian, Liaoning, China., Tian R; Department of Oncology, Dongying District People's Hospital, Dong Ying City, Shandong Province, China., Liu J; Department of Interventional Therapy, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China., Chang X; Department of Interventional Therapy, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China., Ning S; Department of Interventional Therapy, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China., Yu Y; Department of Interventional Therapy, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China., Zhang L; Department of Interventional Therapy, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China. zhanglin20121212@yeah.net.

Journal Article , 2025

Transarterial chemoembolization combined with percutaneous ethanol injection for the treatment of hepatocellular carcinoma at high-risk areas.

Feng W; Department of Interventional Radiology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China., Guo Y; Department of Interventional Radiology, Suzhou Xiangcheng people's Hospital, Suzhou, Jiangsu, China., Lu S; Department of Interventional Radiology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China., Yin Y; Department of Interventional Radiology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China., Xue T; Department of Interventional Radiology, Huaian Hospital of Huaian City, Huaian, Jiangsu, China., Li Z; Department of Interventional Radiology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China.

Journal Article , 2025

The safety and efficacy of tyrosine kinase inhibitors and programmed cell death protein- 1 inhibitors combined with HAIC/TACE in the treatment of recurrent unresectable hepatocellular carcinoma.

Deng W; Department of General Surgery, The First Affiliated Hospital of Nanchang University, Nanchang City, Jiangxi Province, 330006, China., Xie J; Department of General Surgery, The First Affiliated Hospital of Nanchang University, Nanchang City, Jiangxi Province, 330006, China., Wang T; Department of Day Surgery Ward, The First Affiliated Hospital of Nanchang University, Nanchang City, Jiangxi Province, 330006, China., Luo L; Department of General Surgery, The First Affiliated Hospital of Nanchang University, Nanchang City, Jiangxi Province, 330006, China., Zhu G; Department of General Surgery, The First Affiliated Hospital of Nanchang University, Nanchang City, Jiangxi Province, 330006, China., Xiao Y; Department of General Surgery, The First Affiliated Hospital of Nanchang University, Nanchang City, Jiangxi Province, 330006, China., Tao J; Department of General Surgery, The First Affiliated Hospital of Nanchang University, Nanchang City, Jiangxi Province, 330006, China., Lin L; Department of General Surgery, The First Affiliated Hospital of Nanchang University, Nanchang City, Jiangxi Province, 330006, China., Ge X; Department of Pathology, Jiangxi Province, The First Affiliated Hospital of Nanchang University, Nanchang City, 330006, China., Wen W; Department of General Surgery, The First Affiliated Hospital of Nanchang University, Nanchang City, Jiangxi Province, 330006, China., Wang M; Department of General Surgery, The First Affiliated Hospital of Nanchang University, Nanchang City, Jiangxi Province, 330006, China., Yu B; Department of General Surgery, The First Affiliated Hospital of Nanchang University, Nanchang City, Jiangxi Province, 330006, China., Liu Y; Department of General Surgery, The First Affiliated Hospital of Nanchang University, Nanchang City, Jiangxi Province, 330006, China., Luo R; Department of Medical Imaging and Interventional Radiology, Jiangxi Province, The First Affiliated Hospital of Nanchang University, Nanchang City, 330006, China., Wan R; Department of General Surgery, The First Affiliated Hospital of Nanchang University, Nanchang City, Jiangxi Province, 330006, China., Hu Z; Department of General Surgery, The First Affiliated Hospital of Nanchang University, Nanchang City, Jiangxi Province, 330006, China. 854189568@qq.com., Shan R; Department of General Surgery, The First Affiliated Hospital of Nanchang University, Nanchang City, Jiangxi Province, 330006, China. srf1978@126.com.

Journal Article , 2025

Comparative efficacy and safety of transarterial chemoembolization combined with tyrosine kinase inhibitors and immune checkpoint inhibitors versus tyrosine kinase inhibitors and immune checkpoint inhibitors alone in advanced hepatocellular carcinoma: a systematic review and meta-analysis.

Tian H; Department of Hepatobiliary Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1277 Jiefang Avenue, Wuhan, 430022, No, China., Wan C; Department of Hepatobiliary Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1277 Jiefang Avenue, Wuhan, 430022, No, China. wanchidan@hust.edu.cn.

Journal Article; Systematic Review; Meta-Analysis; Comparative Study , 2025

Systemic chemotherapy improves outcome of hepatocellular carcinoma patients treated with transarterial chemoembolization.

Zhang WC; Department of Hepatobiliary and Pancreatic Surgery, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China., Du KY; Zhejiang University School of Medicine, Hangzhou 310000, China., Yu SF; Department of Hepatobiliary and Pancreatic Surgery, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China., Guo XE; Department of Nursing, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China., Yu HX; International Institutes of Medicine, Fourth Affiliated Hospital, Zhejiang University School of Medicine, Yiwu 322000, China., Wu DY; Zhejiang University School of Medicine, Hangzhou 310000, China., Pan C; The 903rd Hospital of PLA, Hangzhou 310000, China., Zhang C; Department of Hepatobiliary and Pancreatic Surgery, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China., Wu J; Department of Hepatobiliary and Pancreatic Surgery, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China., Bian LF; Department of Nursing, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China., Cao LP; Department of Hepatobiliary and Pancreatic Surgery, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China., Yu J; Department of Hepatobiliary and Pancreatic Surgery, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China. Electronic address: dryujun@zju.edu.cn.

Journal Article , 2025

Efficacy and safety of hepatic arterial infusion chemotherapy followed by transarterial embolization for hepatocellular carcinoma.

Yang J; Department of Interventional Radiology, The First Affiliated Hospital of Soochow University, Suzhou, China., Zhang S; Department of Interventional Radiology, The First Affiliated Hospital of Soochow University, Suzhou, China., Yin Y; Department of Interventional Radiology, The First Affiliated Hospital of Soochow University, Suzhou, China., Li Z; Department of Interventional Radiology, The First Affiliated Hospital of Soochow University, Suzhou, China., Lu S; Department of Interventional Radiology, The First Affiliated Hospital of Soochow University, Suzhou, China., Ni G; Department of Interventional Radiology, The First Affiliated Hospital of Soochow University, Suzhou, China., Zhu X; Department of Interventional Radiology, The First Affiliated Hospital of Soochow University, Suzhou, China., Ni C; Department of Interventional Radiology, The First Affiliated Hospital of Soochow University, Suzhou, China.

Journal Article , 2025

Transcatheter arterial infusion chemotherapy combined with lipiodol chemoembolization for advanced gastric fundus and cardia cancer with obstruction.

Zhang J; Department of Interventional Radiology, The First Affiliated Hospital of Zhengzhou University, No.1, Jianshe Road, Zhengzhou, 450052, China., Zhou G; Department of Interventional Radiology, The First Affiliated Hospital of Zhengzhou University, No.1, Jianshe Road, Zhengzhou, 450052, China., Yin M; Department of Interventional Radiology, The First Affiliated Hospital of Zhengzhou University, No.1, Jianshe Road, Zhengzhou, 450052, China., Ma Y; Department of Interventional Radiology, The First Affiliated Hospital of Zhengzhou University, No.1, Jianshe Road, Zhengzhou, 450052, China., He W; Department of Oncology Department, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China., Bi Y; Department of Interventional Radiology, The First Affiliated Hospital of Zhengzhou University, No.1, Jianshe Road, Zhengzhou, 450052, China., Wu G; Department of Interventional Radiology, The First Affiliated Hospital of Zhengzhou University, No.1, Jianshe Road, Zhengzhou, 450052, China. wuganghenan2004@zzu.edu.cn.

Journal Article , 2025

A risk prediction model for nausea and vomiting after TACE: a cross-sectional study.

Dai Y; The 2 nd Affiliated Hospital, Jiangxi Medical College, Nanchang University, JiangXi, 330006, China.; School of Nursing, Jiangxi Medical College, Nanchang University, JiangXi, 330006, China., Zeng M; Jiangxi Cancer Hosptial, JiangXi, 330029, China., He H; The 2 nd Affiliated Hospital, Jiangxi Medical College, Nanchang University, JiangXi, 330006, China. 1811889838@qq.com., Cai M; The 2 nd Affiliated Hospital, Jiangxi Medical College, Nanchang University, JiangXi, 330006, China.; School of Nursing, Jiangxi Medical College, Nanchang University, JiangXi, 330006, China.

Journal Article , 2025

Development and validation of a nomogram for predicting early recurrence in patients undergoing different courses of postoperative adjuvant transarterial chemoembolisation.

Tan H; Department of Hepatobiliary Surgery II, General Surgery Center, Zhujiang Hospital, Southern Medical University, No. 253, Industrial Avenue Zhong, Haizhu District, Guangzhou, 510000, China., Xu Y; Department of Hepatobiliary Surgery II, General Surgery Center, Zhujiang Hospital, Southern Medical University, No. 253, Industrial Avenue Zhong, Haizhu District, Guangzhou, 510000, China., Zhang C; Department of Hepatobiliary Surgery II, General Surgery Center, Zhujiang Hospital, Southern Medical University, No. 253, Industrial Avenue Zhong, Haizhu District, Guangzhou, 510000, China., Zhong K; Department of Hepatobiliary Surgery, Huizhou Municipal Central Hospital, Huizhou, 516001, China., Wen Y; Department of Hepatobiliary Surgery II, General Surgery Center, Zhujiang Hospital, Southern Medical University, No. 253, Industrial Avenue Zhong, Haizhu District, Guangzhou, 510000, China., Wang C; Department of Hepatobiliary Surgery II, General Surgery Center, Zhujiang Hospital, Southern Medical University, No. 253, Industrial Avenue Zhong, Haizhu District, Guangzhou, 510000, China., Feng Z; Department of Hepatobiliary Surgery II, General Surgery Center, Zhujiang Hospital, Southern Medical University, No. 253, Industrial Avenue Zhong, Haizhu District, Guangzhou, 510000, China., Feng J; Department of Hepatobiliary Surgery II, General Surgery Center, Zhujiang Hospital, Southern Medical University, No. 253, Industrial Avenue Zhong, Haizhu District, Guangzhou, 510000, China., Fu S; Department of Hepatobiliary Surgery II, General Surgery Center, Zhujiang Hospital, Southern Medical University, No. 253, Industrial Avenue Zhong, Haizhu District, Guangzhou, 510000, China., He G; Department of Hepatobiliary Surgery II, General Surgery Center, Zhujiang Hospital, Southern Medical University, No. 253, Industrial Avenue Zhong, Haizhu District, Guangzhou, 510000, China., Cai L; Department of Hepatobiliary Surgery II, General Surgery Center, Zhujiang Hospital, Southern Medical University, No. 253, Industrial Avenue Zhong, Haizhu District, Guangzhou, 510000, China. cailei_427@163.com., Pan M; Department of Hepatobiliary Surgery II, General Surgery Center, Zhujiang Hospital, Southern Medical University, No. 253, Industrial Avenue Zhong, Haizhu District, Guangzhou, 510000, China. panmx@smu.edu.cn.

Journal Article; Validation Study , 2025

Predicting hepatocellular carcinoma response to TACE: A machine learning study based on 2.5D CT imaging and deep features analysis.

Lin C; Department of Radiology, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China; Department of Nuclear Medicine, Guizhou Provincial People's Hospital, Affiliated Hospital of Guizhou University, Guiyang, Guizhou, China., Cao T; Department of Radiology, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China; Department of Nuclear Medicine, Guizhou Provincial People's Hospital, Affiliated Hospital of Guizhou University, Guiyang, Guizhou, China., Tang M; Department of Radiology, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China., Pu W; Department of Radiology, Guizhou Provincial People's Hospital, Affiliated Hospital of Guizhou University, Guiyang, Guizhou, China., Lei P; Department of Radiology, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China. Electronic address: pingguilei@foxmail.com.

Journal Article , 2025

The Influence of CYP2B6, GSTP1, and SLCO1B1 Star Allele-Predicted Phenotypes and CBR1 Genetic Variants on Effectiveness Outcomes in Patients With Hepatocellular Carcinoma Receiving Doxorubicin via Transarterial Chemoembolization.

Shilbayeh SAR; Department of Pharmacy Practice, College of Pharmacy, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia., Abd El-Baset OA; Clinical Pharmacy and Pharmacy Practice Department, Faculty of Pharmacy, Egyptian Russian University, Cairo, Egypt., Alshabeeb MA; King Abdullah International Medical Research Center (KAIMRC), King Saud Bin Abdulaziz University for Health Sciences (KSAU-HS), Ministry of National Guard Health, Riyadh, Saudi Arabia., Alanizi AH; Department of Pharmaceutical Care Services, Medical Affairs, King Abdullah Bin Abdulaziz University Hospital, Riyadh, Saudi Arabia., Khedr NF; Biochemistry Department, Faculty of Pharmacy, Tanta University, Tanta, Egypt., Werida RH; Department of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmacy, Damanhour University, Damanhour, Egypt.

Journal Article; Observational Study , 2025

Immune-activated microspheres for enhanced chemoembolization of hepatocellular carcinoma by blocking the adenosine A2A receptor.

Chen M; Zhejiang Key Laboratory of Imaging and Interventional Medicine, School of Medicine, Lishui Hospital of Zhejiang University, Zhejiang, China; Zhejiang Engineering Research Center of Interventional Medicine Engineering and Biotechnology, The Fifth Affiliated Hospital of Wenzhou Medical University, Zhejiang, China; Cixi Biomedical Research Institute, Wenzhou Medical University, Zhejiang, China., Chen Y; Zhejiang Key Laboratory of Imaging and Interventional Medicine, School of Medicine, Lishui Hospital of Zhejiang University, Zhejiang, China., Chen W; Zhejiang Key Laboratory of Imaging and Interventional Medicine, School of Medicine, Lishui Hospital of Zhejiang University, Zhejiang, China; Zhejiang Engineering Research Center of Interventional Medicine Engineering and Biotechnology, The Fifth Affiliated Hospital of Wenzhou Medical University, Zhejiang, China., Chen X; Zhejiang Key Laboratory of Imaging and Interventional Medicine, School of Medicine, Lishui Hospital of Zhejiang University, Zhejiang, China; Zhejiang Engineering Research Center of Interventional Medicine Engineering and Biotechnology, The Fifth Affiliated Hospital of Wenzhou Medical University, Zhejiang, China., Guo X; Zhejiang Key Laboratory of Imaging and Interventional Medicine, School of Medicine, Lishui Hospital of Zhejiang University, Zhejiang, China; Zhejiang Engineering Research Center of Interventional Medicine Engineering and Biotechnology, The Fifth Affiliated Hospital of Wenzhou Medical University, Zhejiang, China., Yu J; Zhejiang Key Laboratory of Imaging and Interventional Medicine, School of Medicine, Lishui Hospital of Zhejiang University, Zhejiang, China; Zhejiang Engineering Research Center of Interventional Medicine Engineering and Biotechnology, The Fifth Affiliated Hospital of Wenzhou Medical University, Zhejiang, China., Guo X; Zhejiang Key Laboratory of Imaging and Interventional Medicine, School of Medicine, Lishui Hospital of Zhejiang University, Zhejiang, China; Zhejiang Engineering Research Center of Interventional Medicine Engineering and Biotechnology, The Fifth Affiliated Hospital of Wenzhou Medical University, Zhejiang, China., Wang M; Zhejiang Engineering Research Center of Interventional Medicine Engineering and Biotechnology, The Fifth Affiliated Hospital of Wenzhou Medical University, Zhejiang, China; Cixi Biomedical Research Institute, Wenzhou Medical University, Zhejiang, China., Zhang X; Zhejiang Engineering Research Center of Interventional Medicine Engineering and Biotechnology, The Fifth Affiliated Hospital of Wenzhou Medical University, Zhejiang, China; Cixi Biomedical Research Institute, Wenzhou Medical University, Zhejiang, China., Hu Q; Zhejiang Engineering Research Center of Interventional Medicine Engineering and Biotechnology, The Fifth Affiliated Hospital of Wenzhou Medical University, Zhejiang, China; Cixi Biomedical Research Institute, Wenzhou Medical University, Zhejiang, China., Fang S; Zhejiang Key Laboratory of Imaging and Interventional Medicine, School of Medicine, Lishui Hospital of Zhejiang University, Zhejiang, China; Zhejiang Engineering Research Center of Interventional Medicine Engineering and Biotechnology, The Fifth Affiliated Hospital of Wenzhou Medical University, Zhejiang, China., Zheng L; Zhejiang Key Laboratory of Imaging and Interventional Medicine, School of Medicine, Lishui Hospital of Zhejiang University, Zhejiang, China; Zhejiang Engineering Research Center of Interventional Medicine Engineering and Biotechnology, The Fifth Affiliated Hospital of Wenzhou Medical University, Zhejiang, China., Zhao Z; Zhejiang Key Laboratory of Imaging and Interventional Medicine, School of Medicine, Lishui Hospital of Zhejiang University, Zhejiang, China; Zhejiang Engineering Research Center of Interventional Medicine Engineering and Biotechnology, The Fifth Affiliated Hospital of Wenzhou Medical University, Zhejiang, China., Du Y; Institute of Pharmaceutics, College of Pharmaceutical Sciences, Zhejiang University, Zhejiang, China. Electronic address: duyongzhong@zju.edu.cn., Shu G; Zhejiang Key Laboratory of Imaging and Interventional Medicine, School of Medicine, Lishui Hospital of Zhejiang University, Zhejiang, China; Zhejiang Engineering Research Center of Interventional Medicine Engineering and Biotechnology, The Fifth Affiliated Hospital of Wenzhou Medical University, Zhejiang, China; Cixi Biomedical Research Institute, Wenzhou Medical University, Zhejiang, China. Electronic address: shugf1208@gmail.com., Ji J; Zhejiang Key Laboratory of Imaging and Interventional Medicine, School of Medicine, Lishui Hospital of Zhejiang University, Zhejiang, China; Zhejiang Engineering Research Center of Interventional Medicine Engineering and Biotechnology, The Fifth Affiliated Hospital of Wenzhou Medical University, Zhejiang, China; School of Medicine, Lishui University, Zhejiang, China. Electronic address: jjstcty@wmu.edu.cn.

Journal Article , 2025

Identification of transarterial chemoembolization candidates in advanced hepatocellular carcinoma patients classified solely by performance status 1: a multicenter retrospective study.

Li J; Department of Digestive Diseases, Shanxi Bethune Hospital, Shanxi Academy of Medical Science, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, Taiyuan, China.; Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.; Shanxi Academy of Advanced Research and Innovation, Taiyuan, China., Wang Z; Department of Hepatobiliary Surgery, General Hospital of Eastern Theater Command, Nanjing, China., Ma L; Department of Gastroenterology, Tangdu Hospital, Air Force Medical University, Xi'an, China., Gou J; Department of Digestive Diseases, Air Force Hospital of Western Theater Command, No. 1 Gongnongyuan Road, Jinjiang District, ChengduSichuan, 610000, China., Feng Y; Department of Digestive Diseases, Air Force Hospital of Western Theater Command, No. 1 Gongnongyuan Road, Jinjiang District, ChengduSichuan, 610000, China., Lou Y; Department of Orthopedic Surgery, Air Force Hospital of Western Theater Command, Chengdu, China., Zuo L; Department of Digestive Diseases, The Second Affiliated Hospital of Chengdu Medical College, Chengdu, China., Wang T; Department of Interventional Radiology, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, Shandong, China., Liang Y; Department of Neurosurgery, General Hospital of Northern Theater Command, No. 83 Wenhua Road, Shenhe District, Shenyang, 110015, Liaoning, China., Zhang Y; Department of Digestive Diseases, Air Force Hospital of Western Theater Command, No. 1 Gongnongyuan Road, Jinjiang District, ChengduSichuan, 610000, China., Wang E; Department of Digestive Diseases, Air Force Hospital of Western Theater Command, No. 1 Gongnongyuan Road, Jinjiang District, ChengduSichuan, 610000, China. 15129202030@163.com., Bai Y; Department of Gastroenterology, Tangdu Hospital, Air Force Medical University, Xi'an, China. sydbaiyang@163.com.; Department of Neurosurgery, General Hospital of Northern Theater Command, No. 83 Wenhua Road, Shenhe District, Shenyang, 110015, Liaoning, China. sydbaiyang@163.com.

Journal Article; Multicenter Study , 2025